Hospital-acquired pneumonia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Antimicrobial therapy== | ==Antimicrobial therapy== | ||
===Patients prone to Methicillin-resistant staphylococcus aureus=== | |||
* Critically ill patients | |||
* Previous antibiotic therapy | |||
* Increased incidence of MRSA hospital | |||
==References== | ==References== |
Revision as of 17:18, 11 September 2012
Hospital-acquired pneumonia Microchapters |
Differentiating Hospital-Acquired Pneumonia from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Hospital-acquired pneumonia medical therapy On the Web |
American Roentgen Ray Society Images of Hospital-acquired pneumonia medical therapy |
Directions to Hospitals Treating Hospital-acquired pneumonia |
Risk calculators and risk factors for Hospital-acquired pneumonia medical therapy |
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Philip Marcus, M.D., M.P.H.[2]
Overview
Antimicrobial therapy
Patients prone to Methicillin-resistant staphylococcus aureus
- Critically ill patients
- Previous antibiotic therapy
- Increased incidence of MRSA hospital